1. ScholarBank@NUS

Yan Junli

rp00589

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Yan Junli
Variants
Yan, J.
 
Main Affiliation
 
Faculty
 
Email
csiyanj@nus.edu.sg
 

Publications

Results 1-11 of 11 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
1Oct-2013Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemiaYan, J. ; Jiang, N.; Huang, G. ; Tay, J.L.-S.; Lin, B.; Bi, C.; Koh, G.S.; Li, Z.; Tan, J.; Chung, T.-H. ; Lu, Y.; Ariffin, H.; Kham, S.K.Y.; Yeoh, A.E.J.; Chng, W.-J.
23-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, Siok-Bian ; Yan, Junli ; Huang, Gaofeng;;rp09940 ; Selvarajan, Viknesvaran; Tay, Jim Liang-Seah; Lin, Baohong; Bi, Chonglei; Tan, Joy; Kwong, Yok-Lam; Shimizu, Norio; Aozasa, Katsuyuki; Chng, Wee-Joo 
33-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, S.-B.; Yan, J. ; Huang, G. ; Selvarajan, V.; Tay, J.L.-S.; Lin, B.; Bi, C.; Tan, J.; Kwong, Y.-L.; Shimizu, N.; Aozasa, K.; Chng, W.-J.
49-Jan-2014Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma (vol 118, pg 4919, 2011)Ng, S-B ; Yan, J ; Huang, G 
530-May-2013EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.Yan, J. ; Ng, S.B.; Tay, J.L.; Lin, B.; Koh, T.L.; Tan, J.; Selvarajan, V.; Liu, S.C.; Bi, C.; Wang, S.; Choo, S.N.; Shimizu, N.; Huang, G.; Yu, Q.; Chng, W.J.
627-Jun-2013Genome-wide Kinase-Chromatin Interactions Reveal the Regulatory Network of ERK Signaling in Human Embryonic Stem CellsGöke, J.; Chan, Y.-S.; Yan, J. ; Vingron, M.; Ng, H.-H. 
72015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
82018LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)Hee, Y.T; Yan, J ; Nizetic, D; Chng, W.-J 
95-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo 
101-Oct-2017RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYCSelvarajan, V ; Osato, M ; Nah, GSS ; Yan, J ; Chung, T-H ; Voon, DC-C ; Ito, Y ; Ham, MF; Salto-Tellez, M ; Shimizu, N; Choo, S-N; Fan, S; Chng, W-J ; Ng, S-B 
118-Jan-2019Towards understanding of PRC2 binding to RNAJunli Yan ; Bibek Dutta; Yan Ting Hee; Wee Joo Chng